
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCB700F925EE6933D700F00385FA34D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses">
<meta name="citation_author" content="Natalie J Galant">
<meta name="citation_author_institution" content="Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7">
<meta name="citation_author" content="Antoinette Bugyei-Twum">
<meta name="citation_author_institution" content="Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7">
<meta name="citation_author" content="Rishi Rakhit">
<meta name="citation_author_institution" content="Department of Chemical and Systems Biology, Stanford University, CA 94305, USA">
<meta name="citation_author" content="Patrick Walsh">
<meta name="citation_author_institution" content="Molecular Structure and Function Program, the Hospital for Sick Children, Department of Biochemistry, University of Toronto, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8">
<meta name="citation_author" content="Simon Sharpe">
<meta name="citation_author_institution" content="Molecular Structure and Function Program, the Hospital for Sick Children, Department of Biochemistry, University of Toronto, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8">
<meta name="citation_author" content="Pharhad Eli Arslan">
<meta name="citation_author_institution" content="Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7">
<meta name="citation_author" content="Per Westermark">
<meta name="citation_author_institution" content="Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden">
<meta name="citation_author" content="Jeffrey N Higaki">
<meta name="citation_author_institution" content="Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.">
<meta name="citation_author" content="Ronald Torres">
<meta name="citation_author_institution" content="Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.">
<meta name="citation_author" content="José Tapia">
<meta name="citation_author_institution" content="Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.">
<meta name="citation_author" content="Avijit Chakrabartty">
<meta name="citation_author_institution" content="Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7">
<meta name="citation_publication_date" content="2016 Apr 28">
<meta name="citation_volume" content="6">
<meta name="citation_firstpage" content="25080">
<meta name="citation_doi" content="10.1038/srep25080">
<meta name="citation_pmid" content="27122057">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/pdf/srep25080.pdf">
<meta name="description" content="Wild-type and mutant transthyretin (TTR) can misfold and deposit in the heart, peripheral nerves, and other sites causing amyloid disease. Pharmacological chaperones, Tafamidis® and diflunisal, inhibit TTR misfolding by stabilizing native tetrameric ...">
<meta name="og:title" content="Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Wild-type and mutant transthyretin (TTR) can misfold and deposit in the heart, peripheral nerves, and other sites causing amyloid disease. Pharmacological chaperones, Tafamidis® and diflunisal, inhibit TTR misfolding by stabilizing native tetrameric ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="4848561">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/srep25080"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/srep25080.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4848561%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/4848561/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/4848561/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2016 Apr 28;6:25080. doi: <a href="https://doi.org/10.1038/srep25080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/srep25080</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galant%20NJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Natalie J Galant</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Natalie J Galant</span></h3>
<div class="p">
<sup>1</sup>Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galant%20NJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Natalie J Galant</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bugyei-Twum%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Antoinette Bugyei-Twum</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Antoinette Bugyei-Twum</span></h3>
<div class="p">
<sup>1</sup>Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bugyei-Twum%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Antoinette Bugyei-Twum</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rakhit%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Rishi Rakhit</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Rishi Rakhit</span></h3>
<div class="p">
<sup>2</sup>Department of Chemical and Systems Biology, Stanford University, CA 94305, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rakhit%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rishi Rakhit</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Walsh%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Patrick Walsh</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Patrick Walsh</span></h3>
<div class="p">
<sup>3</sup>Molecular Structure and Function Program, the Hospital for Sick Children, Department of Biochemistry, University of Toronto, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Walsh%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Patrick Walsh</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharpe%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Simon Sharpe</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Simon Sharpe</span></h3>
<div class="p">
<sup>3</sup>Molecular Structure and Function Program, the Hospital for Sick Children, Department of Biochemistry, University of Toronto, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sharpe%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Simon Sharpe</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arslan%20PE%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Pharhad Eli Arslan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Pharhad Eli Arslan</span></h3>
<div class="p">
<sup>1</sup>Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arslan%20PE%22%5BAuthor%5D" class="usa-link"><span class="name western">Pharhad Eli Arslan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westermark%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Per Westermark</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Per Westermark</span></h3>
<div class="p">
<sup>4</sup>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westermark%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Per Westermark</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Higaki%20JN%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jeffrey N Higaki</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jeffrey N Higaki</span></h3>
<div class="p">
<sup>5</sup>Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Higaki%20JN%22%5BAuthor%5D" class="usa-link"><span class="name western">Jeffrey N Higaki</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Torres%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Ronald Torres</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Ronald Torres</span></h3>
<div class="p">
<sup>5</sup>Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Torres%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ronald Torres</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tapia%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">José Tapia</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">José Tapia</span></h3>
<div class="p">
<sup>5</sup>Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tapia%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">José Tapia</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chakrabartty%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Avijit Chakrabartty</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Avijit Chakrabartty</span></h3>
<div class="p">
<sup>1</sup>Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chakrabartty%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Avijit Chakrabartty</span></a>
</div>
</div>
<sup>1,</sup><sup>a</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="a1">
<sup>1</sup>Princess Margaret Cancer Centre, University Health Network, Departments of Medical Biophysics and Biochemistry, University of Toronto, TMDT 4-305, 101 College Street, Toronto, Ontario, Canada M5G 1L7</div>
<div id="a2">
<sup>2</sup>Department of Chemical and Systems Biology, Stanford University, CA 94305, USA</div>
<div id="a3">
<sup>3</sup>Molecular Structure and Function Program, the Hospital for Sick Children, Department of Biochemistry, University of Toronto, 1 King’s College Circle, Toronto, Ontario, Canada M5S 1A8</div>
<div id="a4">
<sup>4</sup>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden</div>
<div id="a5">
<sup>5</sup>Departments of Biochemistry and Histopathology, Prothena Biosciences Inc., South San Francisco, CA 94080.</div>
<div class="author-notes p">
<div class="fn" id="c1">
<sup>a</sup><p class="display-inline">Email: <span>chakrab@uhnres.utoronto.ca</span></p>
</div>
<div class="fn" id="n1">
<sup>*</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2015 Dec 4; Accepted 2016 Apr 8; Collection date 2016.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2016, Macmillan Publishers Limited</div>
<p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a></p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC4848561  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27122057/" class="usa-link">27122057</a>
</div>
<div class="ra xbox p" role="complementary" aria-label="Related or updated information about this article"><div>
<strong>This article has been corrected.</strong> See <a href="/articles/PMC4901490/" class="usa-link">Sci Rep. 2016 Jun 10;6:27679</a>.</div></div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Wild-type and mutant transthyretin (TTR) can misfold and deposit in the heart, peripheral nerves, and other sites causing amyloid disease. Pharmacological chaperones, Tafamidis<sup>®</sup> and diflunisal, inhibit TTR misfolding by stabilizing native tetrameric TTR; however, their minimal effective concentration is in the micromolar range. By immune-targeting sparsely populated TTR misfolding intermediates (i.e. monomers), we achieved fibril inhibition at substoichiometric concentrations. We developed an antibody (misTTR) that targets TTR residues 89–97, an epitope buried in the tetramer but exposed in the monomer. Nanomolar misTTR inhibits fibrillogenesis of misfolded TTR under micromolar concentrations. Pan-specific TTR antibodies do not possess such fibril inhibiting properties. We show that selective targeting of misfolding intermediates is an alternative to native state stabilization and requires substoichiometric concentrations. MisTTR or its derivative may have both diagnostic and therapeutic potential.</p></section><hr class="headless">
<p>Protein misfolding diseases constitute a significant health care burden, especially in terms of their economic impact and associated costs of care<a href="#b1" class="usa-link" aria-describedby="b1"><sup>1</sup></a>,<a href="#b2" class="usa-link" aria-describedby="b2"><sup>2</sup></a>. Development of effective therapies for protein misfolding diseases requires an understanding of how proteins change from their natural conformation to misfolded pathological forms. In their natural state, proteins can be either structured or intrinsically disordered to perform their physiological function<a href="#b3" class="usa-link" aria-describedby="b3"><sup>3</sup></a>. For those proteins that adopt a unique three-dimensional structure, which in most cases corresponds to the lowest free energy conformation, mutations or changes in environmental conditions can result in destabilization of this low energy state, and lead to misfolding, aggregation, and/or degradation<a href="#b4" class="usa-link" aria-describedby="b4"><sup>4</sup></a>; this misfolding ultimately results in the development of protein misfolding disease.</p>
<p>Although a number of approved drugs for protein misfolding disease are available, they mainly offer symptomatic relief with few addressing the underlying root cause<a href="#b5" class="usa-link" aria-describedby="b5"><sup>5</sup></a>. Protein misfolding diseases are caused by a multi-step pathway that results in the conversion of native proteins into abnormal conformations that lead to fibril formation and aggregation. The misfolding pathway can in many cases be described by a nucleation and growth model<a href="#b6" class="usa-link" aria-describedby="b6"><sup>6</sup></a> or rather a downhill polymerization reaction model<a href="#b7" class="usa-link" aria-describedby="b7"><sup>7</sup></a>. The native protein must first overcome an energetic barrier to populate transient high-energy intermediates. Conversion of these intermediates to aggregates/fibrils is an energetically favorable process, and pre-formed aggregates can ‘seed’ the conversion of other native proteins into the misfolded form. There are several conceptual strategies available for intervention that target different stages in the protein misfolding pathway (<a href="#f1" class="usa-link">Fig. 1A</a>).</p>
<figure class="fig xbox font-sm" id="f1"><h2 class="obj_head">Figure 1.</h2>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4848561_srep25080-f1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/a5f6cb3f5f40/srep25080-f1.jpg" loading="lazy" height="494" width="787" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Proposed model for the inhibition of TTR fibrillogenesis by the misTTR antibody. During the fibril formation process, native tetrameric TTR first dissociates into an altered monomeric intermediate. This altered monomeric intermediate self assembles into stable nuclei, which allows for fibril formation to proceed. Substoichiometric amounts of the misTTR antibody may suppress TTR fibril formation by binding misfolded conformations of the TTR that comprise the critical nuclei, which are likely present at very low concentrations. The misTTR antibody may also act to inhibit TTR fibrillogenesis by binding to the unfolded monomers and/or to the extremities of fibrils, essentially capping the ends of preformed fibrils to prevent fibril growth. (<strong>B</strong>) Surface representation of native tetrameric TTR (green) with buried misTTR epitope in red. (<strong>C</strong>) Surface representation of monomeric TTR (green) with exposed epitope in red. Structures were generated using PDB ID 1DVQ in Deep View (Swiss-PBD Viewer 3.7).</p></figcaption></figure><p>Although the native and fibrillar states are the most stable and more populated species under steady-state conditions, the sparsely populated oligomeric intermediates are the ones which have been directly implicated in cytotoxicity (<em>vida infra</em>)<a href="#b8" class="usa-link" aria-describedby="b8"><sup>8</sup></a>. It follows that effective treatments should reduce the toxic oligomeric intermediates. Current strategies in development include native state stabilization, fibril capping, and aggregate sequestration. However, these only indirectly affect the putative toxic oligomeric intermediates, and mostly target species in the misfolding pathway present at high concentrations, namely the native and fibrillar states.</p>
<p>Native state stabilization strategies utilize small molecules called pharmacological chaperones that prevent aggregation by binding to the native protein, which imposes an energetic barrier to the formation of aggregation-prone misfolding intermediates. Pharmacological chaperones must possess sufficient binding free energy such that they alter the folding equilibrium to de-populate aggregation-prone species on the misfolding pathway. An alternative approach to native-state stabilization that limits aggregation involves capping the ends of growing amyloid fibrils with specific peptides or small molecules<a href="#b9" class="usa-link" aria-describedby="b9"><sup>9</sup></a>,<a href="#b10" class="usa-link" aria-describedby="b10"><sup>10</sup></a>. However, capping aggregates results in the build-up of oligomers and small aggregates which can worsen the problem since oligomeric intermediates have often been shown to be more toxic than the final fibrillar end-product<a href="#b11" class="usa-link" aria-describedby="b11"><sup>11</sup></a>. The concentration of toxic oligomeric species can be reduced by accelerating the aggregation process, as shown when small molecules were used to convert toxic Alzheimer amyloid peptide oligomers into less toxic amyloid fibrils<a href="#b12" class="usa-link" aria-describedby="b12"><sup>12</sup></a>. Small-molecule pharmacological chaperones that stabilize the native state remain the strategy with a relatively good track record of development.</p>
<p>Native tetramer stabilization has been the main approach used to design therapy for a group of protein misfolding diseases caused by the same amyloid-precursor protein, transthyretin. Misfolding of transthyretin (TTR), a human serum transport protein, is the root cause of a group of amyloidoses for which no FDA approved treatment currently exists. TTR is an abundant homotetrameric protein which transports thyroid hormones, T3 and T4, and Vitamin A (in a ternary complex with retinol binding protein) throughout the body<a href="#b13" class="usa-link" aria-describedby="b13"><sup>13</sup></a>. Its primary site of production is the liver, which secretes it into the serum. Secondary sites include the retinal pigment epithelia and the choroid plexus which secretes it into the vitreous humour and cerebrospinal fluid, respectively<a href="#b14" class="usa-link" aria-describedby="b14"><sup>14</sup></a>. Aberrant dissociation of the TTR tetramer into its misfolded monomers leads to formation and deposition of amyloid fibrils at multiple sites throughout the body; these amyloid deposits contain both full-length TTR and proteolytic fragments of TTR<a href="#b15" class="usa-link" aria-describedby="b15"><sup>15</sup></a>. It is believed that the dissociation pathway of the native TTR tetramer is a multi-step process in which the TTR protein cycles through a series of misfolding intermediates before becoming an insoluble amyloid<a href="#b16" class="usa-link" aria-describedby="b16"><sup>16</sup></a>. Although the mechanism of TTR misfolding is uncertain, studies with transgenic mice which over-express TTR suggest that it may be the result of complications either in TTR’s initial folding stages due to defective hepatic chaperones, or during its final stages of clearance as a result of defective proteasomes<a href="#b17" class="usa-link" aria-describedby="b17"><sup>17</sup></a>.</p>
<p>There are two main conditions related to the misfolding of the TTR protein: wild-type TTR amyloidosis (wt-ATTR) and hereditary forms of TTR amyloidosis<a href="#b18" class="usa-link" aria-describedby="b18"><sup>18</sup></a>. wt-ATTR is characterized by wild-type TTR amyloid deposition, while the latter is a heterogeneous group of autosomal dominant diseases caused by mutation in the TTR gene. wt-ATTR involves amyloid deposition in the heart that can result in cardiac insufficiency and death, with secondary deposition in the peripheral nervous system and eye<a href="#b19" class="usa-link" aria-describedby="b19"><sup>19</sup></a>. Deposition of wild-type TTR amyloid can also occur in both cartilage and ligaments and is believed to be the cause of other debilitating diseases such as lumbar spinal stenosis<a href="#b20" class="usa-link" aria-describedby="b20"><sup>20</sup></a>. Additional wt-ATTR co-morbidities include bilateral carpal tunnel syndrome, which is believed to be one of the first signs of wt-ATTR as it precedes wt-ATTR diagnosis by 3–5 years<a href="#b21" class="usa-link" aria-describedby="b21"><sup>21</sup></a>,<a href="#b22" class="usa-link" aria-describedby="b22"><sup>22</sup></a>.</p>
<p>There have been more than 125 different TTR mutations identified in various populations worldwide<a href="#b23" class="usa-link" aria-describedby="b23"><sup>23</sup></a>. The phenotypic expression of these mutations varies but most often results in the development of systemic amyloidosis. A slowly progressing axonal sensory autonomic and motor neuropathy, often called ‘familial amyloidotic polyneuropathy (FAP) or restrictive cardiomyopathy are major consequences<a href="#b24" class="usa-link" aria-describedby="b24"><sup>24</sup></a>. In many cases there is a mixture of these cardinal symptoms.</p>
<p>Current therapeutic strategies used in TTR amyloidosis involve surgical procedures that either remove amyloid infiltrated tissue (i.e. heart transplants) or decrease the concentration of circulating amyloid-prone TTR protein (i.e. liver transplants)<a href="#b22" class="usa-link" aria-describedby="b22"><sup>22</sup></a>. Two recently developed small molecule agents which have successfully displayed <em>in vitro</em> inhibition of fibril formation are diflunisal and Tafamadis<sup>®</sup>. Both drugs are similar in their strategy of tetrameric dissociation inhibition by acting as pharmacological chaperones which directly bind to TTR’s thyroxine binding site at its dimer-dimer interface.</p>
<p>Although diflunisal has been demonstrated to effectively stabilize TTR structure in patients with TTR cardiac amyloidosis, its administration unfortunately compromises glomerular filtration rates and platelet counts<a href="#b22" class="usa-link" aria-describedby="b22"><sup>22</sup></a>. Because diflunisal is an NSAID, administration to elderly patients, especially those with TTR cardiac complications, is contraindicated as a result of its side-effects such as renal failure, peptic ulcer disease, gastritis, and fluid retention<a href="#b22" class="usa-link" aria-describedby="b22"><sup>22</sup></a>. Tafamadis<sup>®</sup>, a benzoxazole derivative, binds to the thyroxine binding pocket, with two molecules of Tafamadis<sup>®</sup> per tetramer. While Tafamadis has no NSAID-associated side effects, near-stoichiometric concentrations (serum TTR ~3.6 μM) would be required in order to effectively reach binding saturation and prevent misfolding<a href="#b25" class="usa-link" aria-describedby="b25"><sup>25</sup></a>. Drug binding leads to tetramer stabilization due to changes in the unfolding equilibrium, and the degree of this stabilization is proportionate to the drug binding free energy. The increase in native state stability leads to reduced concentrations of the unfolded state, lower protein degradation rates, and increased half-life of the native protein<a href="#b26" class="usa-link" aria-describedby="b26"><sup>26</sup></a>. Because Tafimidis<sup>®</sup> binds TTR relatively weakly, with an apparent dissociation constant in the micromolar range<a href="#b27" class="usa-link" aria-describedby="b27"><sup>27</sup></a>, the degree of stabilization is not likely to be large. While Tafamidis<sup>®</sup> has been shown to be a clinically effective pharmacological chaperone in slowing disease progression, this strategy is limited by the need for high drug concentrations, the need for saturation binding to prevent misfolding, tighter binding to confer greater stabilization, and competition with endogenous ligands that may interfere with the protein’s normal function. Although the U.S. Food and Drug Administration (FDA) has indicated that the New Drug Application (NDA) for Tafamidis<sup>®</sup> has not yet been approved<a href="#b28" class="usa-link" aria-describedby="b28"><sup>28</sup></a>, it has received approval for treatment of TTR amyloidosis in Europe, and has been used to treat TTR-FAP in Mexico, Japan, and Argentina<a href="#b29" class="usa-link" aria-describedby="b29"><sup>29</sup></a>.</p>
<p>While small molecule drugs like Tafamidis<sup>®</sup> have the advantages of relative ease of synthesis and high oral bioavailability, macromolecular antibody drugs have other advantages. These include their more specific mechanisms of action than conventional chemotherapeutic agents which often result in fewer associated side effects. They trigger complement-mediated processes that scavenge biological materials. Furthermore, humanized monoclonal antibodies, which are the most common protein drugs entering clinical studies, have higher drug approval rates<a href="#b30" class="usa-link" aria-describedby="b30"><sup>30</sup></a> than new small-molecule drugs<a href="#b31" class="usa-link" aria-describedby="b31"><sup>31</sup></a>.</p>
<p>We used a structure-based approach to develop a TTR conformation-specific antibody that targets the pre-fibrillar, misfolding intermediates of TTR, but not the natively folded protein. This antibody directly targets the sparsely populated non-native misfolding intermediates and can achieve substoichiometric inhibition of fibril formation at nanomolar concentrations.</p>
<section id="sec1"><h2 class="pmc_sec_title">Results and Discussion</h2>
<section id="sec2"><h3 class="pmc_sec_title">Development and validation of misTTR antibody</h3>
<p>The use of antibodies, particularly as structural probes, to investigate the misfolding pathway of amyloidogenic and non-amyloidogenic proteins has been applied in the study of ALS<a href="#b32" class="usa-link" aria-describedby="b32"><sup>32</sup></a>, prion disease<a href="#b33" class="usa-link" aria-describedby="b33"><sup>33</sup></a> and Alzheimer’s disease<a href="#b34" class="usa-link" aria-describedby="b34"><sup>34</sup></a>. The generation of TTR antibodies have often relied on highly destabilized mutant proteins or randomly generated linear sequences of the molecule<a href="#b15" class="usa-link" aria-describedby="b15"><sup>15</sup></a>,<a href="#b35" class="usa-link" aria-describedby="b35"><sup>35</sup></a>,<a href="#b36" class="usa-link" aria-describedby="b36"><sup>36</sup></a>. Using a high resolution X-ray crystal structure of TTR, we sought to develop a conformation-specific antibody which could not only be used as a structural probe of TTR misfolding intermediates, but also as a diagnostic tool for the identification of TTR-related amyloidosis patients, and perhaps even as a therapeutic agent.</p>
<p>Examination of the X-ray crystal structure of TTR (PDB code: 3KGU) revealed that residues 89–97 was the longest segment of TTR that was highly buried (&gt;90%) in the native tetrameric fold of the protein (<a href="#f1" class="usa-link">Fig. 1B</a>). These residues are located in the F-strand that is sequestered at the dimer interface of TTR and inaccessible in the native tetramer. We reasoned that an antibody targeted against this epitope would bind to misfolded TTR conformations with disrupted and exposed dimer interfaces, but not to the native tetramer. This antibody would bind to both monomeric (<a href="#f1" class="usa-link">Fig. 1C</a>) and non-native oligomeric forms of TTR. Since these misfolded species represent only a fraction of serum TTR, this may result in substoichiometric concentrations of the antibody being sufficient for activity. In our strategy, antibody specificity for the misfolded conformation is designed from the outset rather than screened from large libraries.</p>
<p>To generate such an antibody, we first synthesized a multiple antigenic peptide (MAP) where each branch of the dendritic core contained the sequence ggEHAEVVFTAggkg; the capitalized sequences represent residues 89–97 of TTR. Gly-Lys linkers were added to the N and C termini so the peptide epitope would resemble an internal sequence as well as to increase the molecular weight of the MAP antigen for an enhanced immune response. Rabbit anti-sera produced from immunization with the MAP antigen were affinity purified and used in all subsequent experiments described herein. We named this antibody, which was designed to specifically target the misfolded conformations of the TTR protein, ‘misTTR’.</p>
<p>To examine the binding specificity of the misTTR antibody, we tested its reactivity with folded tetrameric TTR and monomeric guanidine hydrochloride (GdnHCl) unfolded TTR<a href="#b37" class="usa-link" aria-describedby="b37"><sup>37</sup></a> using indirect and competitive enzyme-linked immunosorbent assay (ELISA). Our antibody reacts preferentially with monomeric or unfolded TTR compared to native folded TTR in an indirect ELISA (<a href="#f2" class="usa-link">Fig. 2A</a>). We tested the specificity of misTTR in a competition ELISA, where native and monomeric TTR in solution was tested for their ability to compete for binding to unfolded TTR absorbed to the ELISA plate. Native tetrameric TTR in solution was unable to compete (<a href="#f2" class="usa-link">Fig. 2B</a>). Using previously established conditions to generate the monomeric amyloidogenic intermediate<a href="#b37" class="usa-link" aria-describedby="b37"><sup>37</sup></a>,<a href="#b38" class="usa-link" aria-describedby="b38"><sup>38</sup></a> we found that the misTTR antibody was able to bind to this intermediate with an IC<sub>50</sub> value of 63 ± 20 nM (<a href="#f2" class="usa-link">Fig. 2B</a>), suggesting that substoichiometric concentrations are sufficient for effective binding. We note that this is not precisely a binding constant because while the misTTR antibody appears to be mono-specific, it is purified from a polyclonal mixture. As a control, the assay was also performed using a commercially available pan-specific anti-TTR antibody (Sigma-Aldrich) that was raised against natively folded TTR protein. As expected, natively folded TTR was able to compete for antibody binding when this antibody was used (<a href="#S1" class="usa-link">Supplementary Figure S1</a>). The lack of binding by the misTTR antibody to native TTR supports the concept that the selected epitope is indeed buried within the native fold of the protein as predicted from the crystal structure. This also supports our rational design strategy of targeting an epitope accessible for binding only in the misfolded TTR species, and avoiding interactions with normal, natively folded TTR that is also present at high concentrations in patient serum.</p>
<figure class="fig xbox font-sm" id="f2"><h4 class="obj_head">Figure 2. MisTTR antibody selectively binds monomeric, misfolded conformations of TTR.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4848561_srep25080-f2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/6ac63bb0bff3/srep25080-f2.jpg" loading="lazy" height="819" width="787" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Indirect ELISA using monomeric TTR (0.01 mg/mL TTR incubated at 25 °C , pH 3, 44 h), guanidine unfolded TTR (TTR in 6 M guanidine , incubated overnight at 25 °C), folded native TTR and BSA. (<strong>B</strong>) Competition ELISA using guanidine unfolded TTR as bound antigen, with monomeric and tetrameric TTR as competitors, and misTTR as the antibody. IC<sub>50</sub> = 63 ± 20 nM for monomeric TTR’s binding affinity for misTTR. (<strong>C</strong>) Native and SDS-PAGE analysis was performed on wild-type TTR purified from human plasma (purchased from Sigma-Aldrich). For native PAGE analysis, three pairs of sample lanes were run. The first lane consisted of molecular weight markers while the second lane consisted of 2 mg of wild-type TTR. The three pairs of lanes were excised from the gel. The first excised lane pair was stained with Coomassie Blue dye. The second pair was transferred to PDVF membrane and immunoblotted with misTTR antibody. The third pair was similarly transferred to PDVF membrane but immunoblotted with commercial anti-TTR antibody. The same procedure was repeated for an SDS-PAGE counterpart. In the native gels, misTTR did not recognize any species, while anti-TTR recognized putative dimers and higher molecular weight oligomers. In SDS gels misTTR only recognized monomers, while anti-TTR recognized monomers and putative dimers.</p></figcaption></figure><p>Our indirect and competition ELISA results comparing the reactivity of misTTR with folded and monomer/unfolded TTR suggest that our antibody has significant conformational specificity for misfolded TTR. To determine the oligomerization states of TTR bound by misTTR antibody we performed native and denaturing Western blots (<a href="#f2" class="usa-link">Fig. 2C</a>). The pan-specific commercial TTR antibody recognizes native tetrameric TTR, monomeric TTR, and an SDS-resistant TTR dimer in the denaturing Western blot (~35 kDa), whereas the misTTR antibody recognizes only monomeric (~15 kDa) TTR without recognizing native tetrameric TTR (<a href="#f2" class="usa-link">Fig. 2C</a>). The misTTR antibody thus fulfills our design criteria of developing an antibody with very high conformational specificity for misfolded TTR and with reasonable binding strength.</p></section><section id="sec3"><h3 class="pmc_sec_title">MisTTR antibody recognizes TTR amyloid fibrils formed <em>in vitro</em> and in human tissue</h3>
<p>We went on to evaluate the reactivity of the misTTR antibody with TTR amyloid fibrils formed <em>in vitro</em>. To do this, we selected physiologically relevant conditions under which TTR readily misfolds and forms amyloid fibrils (pH 4.5, 37 °C, 3 days)<a href="#b39" class="usa-link" aria-describedby="b39"><sup>39</sup></a>. The aggregates formed under these conditions were able to bind the amyloid specific dye thioflavin T (ThT), causing an enhancement in the fluorescence emission of the dye as well as a characteristic red shift in its emission spectrum (<a href="#S1" class="usa-link">Supplementary Figure S2</a>). The presence of TTR amyloid fibrils under these conditions was also confirmed using negative stain transmission electron microscopy (TEM) (<a href="#f3" class="usa-link">Fig. 3A</a>). The fibrils observed were found to be ~7 nm in diameter and the morphology consistent with previously published reports of fibrillar structures formed by other amyloidogenic proteins<a href="#b8" class="usa-link" aria-describedby="b8"><sup>8</sup></a>,<a href="#b40" class="usa-link" aria-describedby="b40"><sup>40</sup></a>. To determine whether the misTTR antibody would recognize these TTR fibrils formed <em>in vitro</em>, a competition ELISA was performed. TTR fibrils were able to compete with plate-bound GdnHCl-unfolded TTR for binding to misTTR (<a href="#f3" class="usa-link">Fig. 3B</a>). Thus the misTTR antibody was able to selectively bind not only to monomeric, but to fibrillar TTR as well. Interestingly, addition of antibody during the early stages of fibrillogenesis resulted in reduction of total TTR aggregation, but did not affect the morphology of fibers formed (<a href="#S1" class="usa-link">Supplementary Figure S3</a>).</p>
<figure class="fig xbox font-sm" id="f3"><h4 class="obj_head">Figure 3. Recognition of TTR amyloid fibrils by misTTR antibody.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4848561_srep25080-f3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/e4158acdfa09/srep25080-f3.jpg" loading="lazy" height="366" width="787" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/f3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Representative TEM image of amyloid fibrils produced from 1 mg/mL TTR. (<strong>B</strong>) Competition ELISA with misTTR antibody showing selective binding of TTR amyloid fibrils and antigenic peptide.</p></figcaption></figure><p>We then evaluated the reactivity of our anti-misfolded TTR antibodies and isotype controls by immunohistochemical analysis of cardiac tissue from validated cases of TTR amyloidosis. Cardiac amyloids were identified by staining using the dyes Thioflavin T and Congo red (<a href="#f4" class="usa-link">Fig. 4C–E</a>) and were confined primarily to the periphery of blood vessels found in these tissue sections. The misfolded TTR antibody selectively labels these Congo red-positive amyloid deposits with marginal labeling of Congo red-negative, non-amyloid TTR, whereas an isotype control antibody shows complete absence of immunoreactivity to the amyloid in the disease tissue (<a href="#f4" class="usa-link">Fig. 4B</a>).</p>
<figure class="fig xbox font-sm" id="f4"><h4 class="obj_head">Figure 4. Misfolded TTR antibody labels TTR amyloids <em>in vivo</em>.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4848561_srep25080-f4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/ed997cfdf63d/srep25080-f4.jpg" loading="lazy" height="731" width="787" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/f4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Formalin fixed paraffin embedded (FFPE) cardiac tissue sections from a patient with I84S TTR mutation were labeled using misTTR (dark brown, <strong>A</strong>), a non-specific isotype control antibody (dark brown, <strong>B</strong>), or the amyloid specific dyes Thioflavin T or Congo Red (green <strong>C</strong>, red <strong>D</strong>, green <strong>E</strong>).</p></figcaption></figure></section><section id="sec4"><h3 class="pmc_sec_title">Misfolding-specific misTTR antibody reduces fibrillogenesis efficiency</h3>
<p>In order to determine if misTTR antibody binding has an effect on TTR fibril formation, we evaluated the kinetics of the process using UV/VIS absorbance spectroscopy. A time course of TTR fibril formation revealed what appeared to be a nucleated polymerization mechanism, which is consistent with previously published reports<a href="#b39" class="usa-link" aria-describedby="b39"><sup>39</sup></a>,<a href="#b41" class="usa-link" aria-describedby="b41"><sup>41</sup></a>. A lag phase, corresponding to the length of time needed to form the amyloidogenic intermediate, was observed followed by a rapid growth phase, which began to plateau after 60 hours (<a href="#f5" class="usa-link">Fig. 5A</a>). In the presence of the misTTR antibody, however, a change in the kinetic profile of TTR fibrillogenesis occurred. There is an extended time period, lasting around 30 hours, where aggregates do not form, after which rapid aggregation occurs, but the aggregation level reaches only 40% of that seen in the absence of misTTR antibody (<a href="#f5" class="usa-link">Fig. 5A</a>). Thus it appears that the antibody changes the aggregation mechanism from being a well ordered multi-step process to a less efficient nucleation-mediated process.</p>
<figure class="fig xbox font-sm" id="f5"><h4 class="obj_head">Figure 5. Effect of misTTR on TTR fibrillogenesis.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4848561_srep25080-f5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/b8dccb50d4e8/srep25080-f5.jpg" loading="lazy" height="340" width="787" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/f5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) Time course of TTR fibril formation monitored by turbidity (3.6μM, 37 °C, pH 4.5). Substoichiometric amounts of misTTR were added at time 0 and after 30 hours to determine effect on TTR fibrillization process. (<strong>B</strong>) Dose dependent inhibition of TTR fibril formation by misTTR after 72 h. ThT emission peak was integrated from 475 nm to 495 nm and plotted versus antibody concentration (IC<sub>50</sub> = 9.08 ± 0.32 nM).</p></figcaption></figure><p>Although the misTTR antibody was able to prolong the lag phase of TTR fibril formation, we looked to determine if it would have an effect when added to TTR after the fibrillogenesis process had started, namely during the polymerization or growth phase. The addition of substoichiometric amounts of misTTR antibody during the polymerization phase resulted in a slight decrease of the absorbance signal over a span of about 5 hours (<a href="#f5" class="usa-link">Fig. 5A</a>). While this slight decrease could be attributed to a dilution effect, this is highly unlikely due to the volume of antibody added. Since the observed signal decrease was gradual, it is likely that a slight disaggregation of prefibrillar species took place upon addition of the misTTR antibody.</p>
<p>In summary, the turbidity experiments highlight the complex inhibition of TTR fibrillogenesis, which includes a prolonged lag phase and apparent partial aggregation that plateaus at 40% of the level seen in the absence of antibody. To further explore this complexity a different technique was used to investigate the effect of the antibody on TTR fibrillogenesis.</p></section><section id="sec5"><h3 class="pmc_sec_title">Substoichiometric amounts of the misTTR antibody suppresses TTR fibrillogenesis <em>in vitro</em>
</h3>
<p>We investigated the concentration dependence of misTTR inhibition using ThT fluorescence, a technique which measures the formation of amyloid fibrils. Physiological concentrations of TTR were left under fibril formation conditions in the presence of various concentrations of the misTTR antibody for 72 hours, and ThT was used to assess the extent of fibrillogenesis. Strikingly, a dose dependent inhibition of TTR fibrillogenesis was observed with IC<sub>50</sub> = 9.08 ± 0.32 nM. Substoichiometric concentrations of the misTTR antibody were sufficient to suppress TTR fibrillogenesis <em>in vitro</em> (<a href="#f5" class="usa-link">Fig. 5B</a>). To confirm that the observed inhibitory effect is a consequence of the conformational specificity of the misTTR antibody, the experiment was repeated using the commercially available anti-TTR antibody. The pan-specific antibody, which displays no preference for native tetrameric TTR or misfolded conformations, had no effect on TTR fibrillogenesis, as assessed by ThT (<a href="#f5" class="usa-link">Fig. 5B</a>); it could neither stabilize the native fold of TTR nor prevent the dissociation and self-assembly of TTR into amyloid fibrils under the conditions used. As a third control, a polyclonal antibody directed against the tumor suppressor protein p53 also showed no effect. As such, we propose that the inhibition of TTR fibril formation is not a generic feature of polyclonal antibodies or even TTR antibodies, but likely stems from the design, specificity, and affinity of the misTTR antibody for monomeric, misfolded conformations of TTR present in the fibrillogenesis pathway.</p>
<p>To assess whether the misTTR polyclonal antibody was only effective at inhibiting wild-type TTR protein amyloidosis, the antibody was subject to a pH-induced aggregation experiment using the designed mutant, TTR Y78F, which exhibits misfolding and aggregation formation at a higher pH than wild-type TTR<a href="#b42" class="usa-link" aria-describedby="b42"><sup>42</sup></a>. Results of this experiment showed the antibody to be just as effective at inhibiting mutant TTR aggregation (<a href="#S1" class="usa-link">Supplementary Figure S4</a>). These results indicate that the misTTR antibody was not only specific to the non-tetrameric, pathological misfolding intermediates of the normal TTR amyloidosis pathway, but also effective at inhibiting the aggregation of both wild-type and non-wild type TTR.</p>
<p>While the ThT fluorescence measurements indicate that the misTTR antibody completely inhibits TTR fibrillogenesis, the turbidity experiment revealed a complex inhibition involving a prolonged lag phase with partial aggregation reaching 40% of control. These differences are likely caused by the fact that ThT fluorescence measures amyloid fibril formation, while turbidity measurements gauge all forms of aggregation. The final aggregation products of these experiments may constitute a mixture of amyloid fibrils and nonspecific aggregates. Consequently, our results suggest that while this antibody inhibits TTR fibrillogenesis, it may not inhibit the formation of nonspecific aggregates.</p></section><section id="sec6"><h3 class="pmc_sec_title">Proposed model of the inhibition of fibrillogenesis by the misfolding-specific misTTR antibody</h3>
<p>The proposed mechanism by which misTTR antibody inhibits TTR fibrillogenesis is illustrated in <a href="#f1" class="usa-link">Fig. 1A</a>. Based on the data presented, we propose that the substoichiometric amounts of the developed antibody may act to suppress TTR fibrillogenesis in one of two ways. The first is as a disrupter of nuclei formation. During the course of fibrillogenesis, several TTR subunits associate to form a core or nucleus before cooperative growth can occur. However, since the association of subunits into a nucleus is an energetically unfavourable process, the lag phase generally persists for a period of time until a stable nucleus is formed. At a molar ratio of ~1:130 (antibody to TTR), misTTR antibody likely binds to small, oligomeric structures that are transiently populated during the lag phase and thereby delay the onset of polymerization. Binding to such structures may disrupt the assembly of stable nuclei needed for fibril growth. A second way by which the misTTR antibody may act to suppress TTR fibrillogenesis is by acting as a cap. At substoichiometric concentrations, misTTR antibody may prevent fibril formation by capping the ends of prefibrillar species and preventing growth.</p>
<p>In a recent publication, Eisenberg and coworkers<a href="#b43" class="usa-link" aria-describedby="b43"><sup>43</sup></a> report the development of two peptide-based inhibitors of TTR aggregation. These peptides were designed using the computational method ZipperDB<a href="#b44" class="usa-link" aria-describedby="b44"><sup>44</sup></a> to locate regions of the TTR sequence that had high fibril formation propensity. These peptide sequences were modified by substituting natural amino acids with N-methyl amino acids and by appending a tetra-arginine tail to either the N- or C-terminal. The peptides showed strong inhibition of TTR aggregation at concentrations above 20 μM. The first peptide corresponds to residues 91–96 of TTR. This segment is found right in the middle of our epitope (residues 89–97) (<a href="#f6" class="usa-link">Fig. 6</a>). This finding may be a coincidence or it may indicate that fibril formation initiation sites consist of buried segments of high fibril formation propensity. The fact that the peptide and the misTTR antibody both inhibited TTR fibril formation suggests that this region of TTR is exposed in misfolding intermediates and perhaps is also exposed on the growing ends of the fibril. The second peptide inhibitor is derived from residues 119–124 of TTR, which corresponds to the second region of TTR that is buried in the tetramer but exposed in the monomer (<a href="#f6" class="usa-link">Fig. 6</a>). We had previously examined an epitope peptide that includes this buried area (residues 105–120), but unfortunately that peptide did not elicit an immune response in rabbits and could not be investigated further. Combining our results with those of Eisenberg and coworkers<a href="#b43" class="usa-link" aria-describedby="b43"><sup>43</sup></a>, we suggest that fibril initiation sites are particular segments of high fibril propensity that are buried in the native state, but become exposed in early, sparsely populated fibril intermediates, such as monomeric TTR. These sites appear to be ideal targets for both therapeutic antibodies and small molecule drugs.</p>
<figure class="fig xbox font-sm" id="f6"><h4 class="obj_head">Figure 6. Correlation of solvent excluded surface area of tetrameric and monomeric TTR with peptide inhibitor segments and the misTTR epitope.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/146d77293c52/srep25080-f6.jpg" loading="lazy" height="535" width="700" alt="Figure 6"></p>
<div class="p text-right font-secondary"><a href="figure/f6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The solvent excluded surface area (SES) of monomeric and the tetramer subunit form of TTR was calculated using Chimera molecular visualization program<a href="#b47" class="usa-link" aria-describedby="b47"><sup>47</sup></a> using the coordinate file 3KGU. The peptide inhibitors are those developed by Saelices <em>et al</em>.<a href="#b43" class="usa-link" aria-describedby="b43"><sup>43</sup></a>. Note the correlation of the locations of the misTTR epitope and inhibitor peptides with changes in SES associated with monomerization of TTR.</p></figcaption></figure></section><section id="sec7"><h3 class="pmc_sec_title">Concluding remarks</h3>
<p>Using a structure-guided approach, we have designed the misTTR antibody which is able to distinguish between native and misfolded conformations of TTR. MisTTR is the first antibody to show inhibition of TTR fibrillogenesis, and more importantly, it achieves aggregation inhibition at low substoichiometric concentrations (IC<sub>50</sub> = 9.08 ± 0.32 nM). Our findings suggest that this antibody has the potential to be used as a diagnostic tool in the identification of those patients with TTR amyloidoses. Furthermore, monoclonal versions of the misTTR antibody may have therapeutic potential for the treatment of FAP, hereditary ATTR, and wt-ATTR by acting as opsonization agents and facilitating clearance of both misfolded TTR and TTR aggregates using the mononuclear phagocytic system<a href="#b45" class="usa-link" aria-describedby="b45"><sup>45</sup></a>. This work suggests there is value in investigating whether other oligomeric misfolding diseases involve the exposure of high-aggregation propensity segments in early stage monomeric misfolding intermediates.</p></section></section><section id="sec8"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec9"><h3 class="pmc_sec_title">Antibody generation</h3>
<p>To generate the misTTR antibody, peptide synthesis was carried out using standard fluorenylmethoxycarbonyl (Fmoc)-based chemistry on a PS3 Automated Solid Phase Peptide Synthesizer (Protein Technologies Inc). A MAP with the following sequence, GGEHAEVVFTAGGKG, was synthesized on an [Fmoc-Lys(Fmoc)]4-Lys2-Lys-βAla-Wang resin (Advanced ChemTech, SM5102) using Fmoc-protected amino acids (Advanced ChemTech, Applied Biosystems, and Novabiochem). The peptide was subsequently cleaved from the resin with a mixture consisting of 90% trifluoroacetic acid, 8% anisole, and 2% triisopropylsilane (all from Sigma-Aldrich) and purified using ether extractions of protecting groups and scavengers; peptide composition was later verified using amino acid analysis. The MAP was then sent to Sigma-Genosys for rabbit antiserum production, which followed standard protocol (Sigma-Genosys) and was in accordance with the Animal Welfare Act (USA).</p></section><section id="sec10"><h3 class="pmc_sec_title">Antibody purification</h3>
<p>To purify the misTTR antibody from rabbit antiserum, a linear peptide with an identical sequence as the antigen used for antibody production was synthesized onto a non-cleavable TentaGel-SH resin (Advanced ChemTech). The resin was deprotected, acetylated, and packed into disposable columns (Evergreen Scientific). Columns were equilibrated with Phosphate-buffered saline containing 0.05% Tween-20 (PBS-T) before being used for rabbit antiserum purification.</p>
<p>For purification, rabbit antiserum (1 mL) was first pre-cleared by centrifugation (16,000 g), after which an equal volume of saturated ammonium sulfate was added. After one hour incubation at 4 °C, precipitate was recovered by centrifugation and washed several times with 50% saturated ammonium sulfate. The precipitate was then dissolved in PBS-T and added to the affinity purification TentaGel column. The column was subsequently incubated overnight at 4 °C, with end-over-end rotation, to allowing for binding to occur. The antibody-bound column was washed with PBS-T at room temperature until the wash eluent contained little or no protein (A<sub>280</sub> = 0). Antibody fractions (1 mL) were eluted from column using 100 mM citric acid, pH 2.8, into tubes containing 250 μL of 1.5 M Tris and 150 mM NaCl, pH 8.0. The concentration of antibody in each fraction was determined using ultraviolet absorption spectroscopy and an IgG extinction coefficient at 280 nm of 1.35 (mg/mL)<sup>−1</sup>. The affinity purified antibody was stored at 4 °C and was generally stable for about 1 month.</p></section><section id="sec11"><h3 class="pmc_sec_title">Protein expression and purification</h3>
<p>A pET 21a (+) expression vector carrying TTR-(His)<a href="#b6" class="usa-link" aria-describedby="b6"><sup>6</sup></a> was transformed into Escherichia coli BL21-A1 competent cells (Invitrogen). Protein expression was induced with 1 mM isopropyl-β-D-thiogalactopyranoside when an absorbance (A<sub>600</sub>) of ~0.6 was reached. After 12–16 h incubation at 20 °C, cells were harvested by centrifugation at 5000 g. Pelleted cells were re-suspended in Buffer A (50 mM phosphate, 300 mM NaCl, 10 mM imidazole, and 20 mM β-mercaptoethanol, pH 8.0) and lysed by passage through an Emulsiflex-C5 (Avastin) for three cycles at 4 °C. After centrifugation at 27,000 g for 30 min at 4 °C, the supernatant was added to 5 mL of nickel-NTA (nitrilotriacetic acid) agarose slurry (Qiagen), gently mixed for 1 h, and loaded onto a column. The column was washed several times with Buffer B (50 mM phosphate, 300 mM NaCl, 20 mM imidazole, and 20 mM β-mercaptoethanol, pH 8.0) and the fusion protein was eluted using Buffer C (50 mM phosphate, 300 mM NaCl, 250 mM imidazole, and 20 mM β-mercaptoethanol, pH 8.0). The protein solution was dialyzed extensively against 10 mM phosphate, aliquotted, and frozen at −20 °C for later use.</p>
<p>The purity of the protein solution was confirmed by size exclusion chromatography. TTR eluted as a single peak at ~11 mL, representing tetrameric TTR, as shown in <a href="#S1" class="usa-link">Supplementary Figure S2</a>. Experiments were performed using recombinant TTR as well as wild-type TTR isolated from human plasma (Sigma-Aldrich). The biophysical properties of both plasma and recombinant TTR were found to be identical.</p></section><section id="sec12"><h3 class="pmc_sec_title">TTR fibril formation assay</h3>
<p>A stock solution of TTR (5 mg/mL) was diluted with 50 mM sodium acetate, pH 4.5, to a final concentration of 0.2 mg/mL. Samples were then incubated at 37 °C for 72 hours. The extent of fibril formation was probed by turbidity measurements at 400 nm on a Jasco V-500 UV-visible spectrometer equipped with a temperature control unit. Thioflavin T (ThT) was also used to assess the extent of fibril formation. In brief, a five-fold molar excess of ThT (Sigma-Aldrich) was added to each sample and left at room temperature for 30 minutes before measurements were taken. ThT fluorescence was monitored using a Photon Technology International C60 specrofluorimeter with the excitation and emission slit widths set to 4 nm. Spectra were obtained by scanning the fluorescence emission from 450 nm to 600 nm, with excitation at 442 nm.</p></section><section id="sec13"><h3 class="pmc_sec_title">Enzyme-linked immunosorbent assay (ELISA)</h3>
<p>To examine the ability of the developed antibody to discriminate between native and non-native conformations of the TTR, competition ELISA experiments were performed. For all assays, TTR unfolded in the presence of 6 M guanidine-HCl<a href="#b37" class="usa-link" aria-describedby="b37"><sup>37</sup></a> was used as bound antigen, while folded tetrameric TTR, monomeric TTR<a href="#b39" class="usa-link" aria-describedby="b39"><sup>39</sup></a>, and TTR fibrils were used as competitors. In brief, a 96-well plate was coated with 100 ng of GdnHCl unfolded TTR per well and incubated overnight at room temperature (pH 4.5). Each well was washed three times with PBS-T and subsequently blocked with PBS + 1% bovine serum albumin (BSA) w/v (Sigma-Aldrich) for two hours. Various concentrations of competitor (folded TTR, monomeric TTR, or TTR fibrils) in the presence of 1 μg/mL of affinity purified misTTR or a commercially available anti-TTR antibody (Sigma-Aldrich) were added to wells and incubated for 1 h at room temperature. Wells were washed with PBS-T, and an HRP-conjugated anti-rabbit or anti-goat secondary antibody (1:5000) was added to wells and incubated at room temperature for 2 h. Wells were washed with PBS-T and 100 μL of the chromogenic substrate tetramethylbenzidine (Sigma Aldrich) was added. The reaction was stopped with 2M H<sub>2</sub>SO<sub>4</sub>, and an absorbance reading at 450 nm of the ELISA plate was taken immediately using a plate reader (SpectraMax M5, Molecular Devices).</p>
<p>All reported IC<sub>50</sub> values were determined by fitting competition ELISA data to the following equation: <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="d33e581"><img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f00/4848561/22568230e321/srep25080-m1.jpg" loading="lazy" id="d33e582" alt="Inline graphic"></span>.</p></section><section id="sec14"><h3 class="pmc_sec_title">Western Blots</h3>
<p>15% native-PAGE and SDS-PAGE gels were run using the protocol as outlined in Sechi and Chait’s publication in Analytical Chemistry (1998)<a href="#b46" class="usa-link" aria-describedby="b46"><sup>46</sup></a>. However, 1/3 of the gel was removed and subject to coomassie staining as a visual reference. The remaining 2/3 of the gel were subject to immunoblots, with ½ of the remainder used for immunblotting with misTTR and the other ½ used for immunblotting with an anti-TTR rabbit antibody as a control (Sigma-Aldrich, #HPA002550) . Sample lanes consisted of 2 μg of lyophilized human TTR (Sigma-Aldrich) and was used Nitrocellulose membrane (Pall Life Sciences) was pre-soaked in PBS, pH 7.4 for 5 min and transferred into a PBS solution containing 20% methanol. The blot was blocked overnight at 4 °C with 5% skim milk, washed several times with PBS-T, and incubated at room temperature with affinity purified misTTR or anti-TTR antibody for 1 hour (1:1000). After several washes, the blot was incubated with IRDye<sup>®</sup> 800CW Goat anti-Rabbit secondary antibody (Li-cor Biosciences, #925-32211) (1:5000) for 1 h, and imaged using LICOR<sup><strong>®</strong></sup> Western Blot Analysis Software.</p></section><section id="sec15"><h3 class="pmc_sec_title">Electron microscopy</h3>
<p>The TTR sample in <a href="#f3" class="usa-link">Fig. 3A</a> was imaged using a Joel 1011 microscope operating at 80 kV. Samples were deposited on fresh continuous carbon films prepared from copper rhodium grids (Electron Microscopy Sciences). Grids were charged using a glow discharger for 15 seconds at 3 mA negative discharge before adding samples. Fibril solutions of 1 mg/mL were adsorbed to grids for 2 minutes before rinsing with 10 μL ddH20 for 10 seconds. Samples were then blotted using No. 2 Whatman Filter paper and stained with freshly filtered 2% uranyl acetate for 15 seconds.</p>
<p><a href="#S1" class="usa-link">Supplementary Figure S3</a>’s TTR samples (0.2 mg/mL WT TTR in 140 mM NH<sub>4</sub>CH<sub>3</sub>COO, pH 4.5) were incubated with and without 70 nM misTTR antibody for 72 hours at 37 °C and 600RPM agitation. Samples were imaged using a Joel 1200 microscope operating at 80 kV at 1 hr, 24 hr, and 48 hr time points. Samples were deposited on carbon films prepared from copper rhodium grids (Electron Microscopy Sciences). Grids were charged using a glow discharger for 4–5 seconds at 3 mA prior to sample deposition. Samples were allowed 60 seconds for binding prior to wicking off with No. 2 Whatman Filter paper and then stained with freshly filtered 2% uranyl acetate for 10 seconds.</p></section><section id="sec16"><h3 class="pmc_sec_title">Histology and Immunohistochemistry</h3>
<p>Histochemical and immunohistochemical labeling was performed on 5 micron formalin fixed paraffin embedded sections of cardiac tissue from a patient with the TTR mutation I84S and confirmed ATTR amyloidosis. Congo red and Thioflavin T stains were used to demonstrate the presence of amyloid in the tissue. Congo red stain was performed using an alkaline Congo red solution (T3516-25G; Sigma-Aldrich, St. Louis, MO) following Pucthler’s modified protocol and Thioflavin T staining was performed with a filtered solution of 0.015% Thioflavin T (T3516-25G; Sigma-Aldrich, St. Louis, MO) in 50% ethanol.</p>
<p>Immunohistochemistry was conducted on a Leica Bond Rx (Leica Biosystems, Buffalo Grove, IL) autostainer using Leica’s proprietary Bond Polymer Refine Detection kit (DS980). The immunoperoxidase method was the principal detection system. The slides were incubated with 0. 5 μg/mL of the misTTR primary antibodies for 1 hour followed by incubation in anti-rabbit polymeric HRP-linker secondary antibody conjugates. The staining was visualized with a DAB chromogen, which produced a brown precipitate. The slides were counterstained with hematoxylin, dehydrated in an ascending series of alcohols, cleared in xylenes, and coverslipped with CytoSeal 60.</p>
<p>Negative controls consisted of performing the entire immunohistochemical procedure on adjacent sections of ATTR cardiac sections with a non-immune rabbit IgG isotype control and an omission of the primary antibody. Positive control slides included staining of sections of normal human choroid plexus and normal pancreas.</p>
<p>Slides were viewed with an Olympus BX61 microscope equipped with a 10x/0.40 and a 20x.0.75 UPlanSApo objective. Congo red-stained sections were evaluated under a cross-polarizer and analyzer while Thioflavin T was visualized in the fluorescence using appropriate FITC excitation and emission filters (Chroma Technology Corp., Bellows Falls, VT). Images were acquired with a Retiga Exi digital camera (QImaging; Surrey, BC) and imported with MetaMorph imaging system (Version 7.6.4.0; Molecular Devices; Sunnyvale, CA). All images were acquired and stored as Olympus Tiff files.</p>
<p>Whole-slides were digitally scanned with a Hamamatsu Nanozoomer 2.0HT slide scanner (Hamamatsu Corporation, Bridgewater, NJ) fitted with an Olympus 20x/0.75 UPlanSApo objective (Olympus).</p></section></section><section id="sec17"><h2 class="pmc_sec_title">Additional Information</h2>
<p><strong>How to cite this article</strong>: Galant, N. J. <em>et al</em>. Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses. <em>Sci. Rep</em>. <strong>6</strong>, 25080; doi: 10.1038/srep25080 (2016).</p></section><section id="S1"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="d33e26"><div class="caption p"><span>Supplementary Information</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/4848561/bin/srep25080-s1.pdf" data-ga-action="click_feat_suppl" class="usa-link">srep25080-s1.pdf</a><sup> (917.7KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This study was supported by a grant from the Canadian Institutes of Health Research to A.C and support from Prothena Inc. PW was supported by FAMY, FAMY Norrbotten and Amyl, and Erik, Karin and Gösta Selander’s Foundation. We thank Drs. D. Bateman and R. Wickner (National Institutes of Health, Bethesda, MD) for providing the pET 21a(+) expression vector used in this study.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn2"><p>This work was supported in part by Prothena Inc.</p></div>
<div class="fn p" id="fn3"><p><strong>Author Contributions</strong> A.B.-T., N.J.G. and R.R. designed the experiments, performed the experiments, made the figures, and wrote the manuscript. P.W., S.S. and P.E.A. performed experiments, made figures, and wrote the manuscript. R.T. and J.T. performed experiments and made figures. P.W. supplied materials, interpreted data and wrote the manuscript. J.N.H. and A.C. designed the experiments, made the figures, and wrote the manuscript.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ol class="ref-list font-sm">
<li id="b1">
<cite>Ernst R. L. &amp; Hay J. W.
The US economic and social costs of Alzheimer’s disease revisited. Am. J. Public Health
84, 1261–1264 (1994).</cite> [<a href="https://doi.org/10.2105/ajph.84.8.1261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1615456/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8059882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Public%20Health&amp;title=The%20US%20economic%20and%20social%20costs%20of%20Alzheimer%E2%80%99s%20disease%20revisited&amp;author=R.%20L.%20Ernst&amp;author=J.%20W.%20Hay&amp;volume=84&amp;publication_year=1994&amp;pages=1261-1264&amp;pmid=8059882&amp;doi=10.2105/ajph.84.8.1261&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b2">
<cite>Gladman M. &amp; Zinman L.
The economic impact of amyotrophic lateral sclerosis: a systematic review. Expert Rev. Pharmacoecon. Outcomes Res.
15, 439–450 (2015).</cite> [<a href="https://doi.org/10.1586/14737167.2015.1039941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25924979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Rev.%20Pharmacoecon.%20Outcomes%20Res.&amp;title=The%20economic%20impact%20of%20amyotrophic%20lateral%20sclerosis:%20a%20systematic%20review&amp;author=M.%20Gladman&amp;author=L.%20Zinman&amp;volume=15&amp;publication_year=2015&amp;pages=439-450&amp;pmid=25924979&amp;doi=10.1586/14737167.2015.1039941&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b3">
<cite>Dunker A. K., Obradovic Z., Romero P., Garner E. C. &amp; Brown C. J.
Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform.
11, 161–171 (2000).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11700597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Inform.%20Ser.%20Workshop%20Genome%20Inform.&amp;title=Intrinsic%20protein%20disorder%20in%20complete%20genomes&amp;author=A.%20K.%20Dunker&amp;author=Z.%20Obradovic&amp;author=P.%20Romero&amp;author=E.%20C.%20Garner&amp;author=C.%20J.%20Brown&amp;volume=11&amp;publication_year=2000&amp;pages=161-171&amp;pmid=11700597&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b4">
<cite>Knowles T. P., Vendruscolo M. &amp; Dobson C. M.
The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol.
15, 384–396 (2014).</cite> [<a href="https://doi.org/10.1038/nrm3810" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24854788/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;title=The%20amyloid%20state%20and%20its%20association%20with%20protein%20misfolding%20diseases&amp;author=T.%20P.%20Knowles&amp;author=M.%20Vendruscolo&amp;author=C.%20M.%20Dobson&amp;volume=15&amp;publication_year=2014&amp;pages=384-396&amp;pmid=24854788&amp;doi=10.1038/nrm3810&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b5">
<cite>Cummings J. L., Isaacson R. S., Schmitt F. A. &amp; Velting D. M.
A practical algorithm for managing Alzheimer’s disease. Ann. Clin. Transl. Neurol.
2, 307–323 (2015).</cite> [<a href="https://doi.org/10.1002/acn3.166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4369281/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25815358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Clin.%20Transl.%20Neurol.&amp;title=A%20practical%20algorithm%20for%20managing%20Alzheimer%E2%80%99s%20disease&amp;author=J.%20L.%20Cummings&amp;author=R.%20S.%20Isaacson&amp;author=F.%20A.%20Schmitt&amp;author=D.%20M.%20Velting&amp;volume=2&amp;publication_year=2015&amp;pages=307-323&amp;pmid=25815358&amp;doi=10.1002/acn3.166&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b6">
<cite>Jarrett J. T. &amp; Lansbury P. T.
Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie?
Cell.
73, 1055–1058 (1993).</cite> [<a href="https://doi.org/10.1016/0092-8674(93)90635-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8513491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell.&amp;title=Seeding%20%E2%80%9Cone-dimensional%20crystallization%E2%80%9D%20of%20amyloid:%20a%20pathogenic%20mechanism%20in%20Alzheimer%E2%80%99s%20disease%20and%20scrapie?&amp;author=J.%20T.%20Jarrett&amp;author=P.%20T.%20Lansbury&amp;volume=73&amp;publication_year=1993&amp;pages=1055-1058&amp;pmid=8513491&amp;doi=10.1016/0092-8674(93)90635-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b7">
<cite>Hurshman A. R., White J. T., Powers E. T. &amp; Kelly J. W.
Transthyretin Aggregation under Partially Denaturing Conditions Is a Downhill Polymerization. Biochemistry
43, 7365–7381 (2004).</cite> [<a href="https://doi.org/10.1021/bi049621l" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15182180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Transthyretin%20Aggregation%20under%20Partially%20Denaturing%20Conditions%20Is%20a%20Downhill%20Polymerization&amp;author=A.%20R.%20Hurshman&amp;author=J.%20T.%20White&amp;author=E.%20T.%20Powers&amp;author=J.%20W.%20Kelly&amp;volume=43&amp;publication_year=2004&amp;pages=7365-7381&amp;pmid=15182180&amp;doi=10.1021/bi049621l&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b8">
<cite>Walsh P., Simonetti K. &amp; Sharpe S.
Core structure of amyloid fibrils formed by residues 106–126 of the human prion protein. Structure
17, 417–26 (2009).</cite> [<a href="https://doi.org/10.1016/j.str.2008.12.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19278656/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Structure&amp;title=Core%20structure%20of%20amyloid%20fibrils%20formed%20by%20residues%20106%E2%80%93126%20of%20the%20human%20prion%20protein&amp;author=P.%20Walsh&amp;author=K.%20Simonetti&amp;author=S.%20Sharpe&amp;volume=17&amp;publication_year=2009&amp;pages=417-26&amp;pmid=19278656&amp;doi=10.1016/j.str.2008.12.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b9">
<cite>Soto C.
et al. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer’s therapy. Nat Med.
4, 822–826 (1998).</cite> [<a href="https://doi.org/10.1038/nm0798-822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9662374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med.&amp;title=%CE%B2-sheet%20breaker%20peptides%20inhibit%20fibrillogenesis%20in%20a%20rat%20brain%20model%20of%20amyloidosis:%20implications%20for%20Alzheimer%E2%80%99s%20therapy&amp;author=C.%20Soto&amp;volume=4&amp;publication_year=1998&amp;pages=822-826&amp;pmid=9662374&amp;doi=10.1038/nm0798-822&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b10">
<cite>Gibson T. J. &amp; Murphy R. M.
Inhibition of insulin fibrillogenesis with targeted peptides. Prot. Sci.
15, 1133–1141 (2006).</cite> [<a href="https://doi.org/10.1110/ps.051879606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2242521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16597825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Prot.%20Sci.&amp;title=Inhibition%20of%20insulin%20fibrillogenesis%20with%20targeted%20peptides&amp;author=T.%20J.%20Gibson&amp;author=R.%20M.%20Murphy&amp;volume=15&amp;publication_year=2006&amp;pages=1133-1141&amp;pmid=16597825&amp;doi=10.1110/ps.051879606&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b11">
<cite>Walsh D. M. &amp; Selkoe D. J.
Aβ oligomers - a decade of discovery. J. Neurochem.
101, 1172–1184 (2007).</cite> [<a href="https://doi.org/10.1111/j.1471-4159.2006.04426.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17286590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurochem.&amp;title=A%CE%B2%20oligomers%20-%20a%20decade%20of%20discovery&amp;author=D.%20M.%20Walsh&amp;author=D.%20J.%20Selkoe&amp;volume=101&amp;publication_year=2007&amp;pages=1172-1184&amp;pmid=17286590&amp;doi=10.1111/j.1471-4159.2006.04426.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b12">
<cite>Bieschke J.
et al. Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils. Nat. Chem. Biol.
8, 93–101 (2011).</cite> [<a href="https://doi.org/10.1038/nchembio.719" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22101602/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Chem.%20Biol.&amp;title=Small-molecule%20conversion%20of%20toxic%20oligomers%20to%20nontoxic%20%CE%B2-sheet%E2%80%93rich%20amyloid%20fibrils&amp;author=J.%20Bieschke&amp;volume=8&amp;publication_year=2011&amp;pages=93-101&amp;pmid=22101602&amp;doi=10.1038/nchembio.719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b13">
<cite>Lim K. H., Dyson J., Kelly J. W. &amp; Wright P. E.
Localized structural fluctuations promote amyloidogenic conformations in transthyretin. J. Mol. Biol.
425, 977–988 (2013).</cite> [<a href="https://doi.org/10.1016/j.jmb.2013.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3594634/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23318953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Localized%20structural%20fluctuations%20promote%20amyloidogenic%20conformations%20in%20transthyretin&amp;author=K.%20H.%20Lim&amp;author=J.%20Dyson&amp;author=J.%20W.%20Kelly&amp;author=P.%20E.%20Wright&amp;volume=425&amp;publication_year=2013&amp;pages=977-988&amp;pmid=23318953&amp;doi=10.1016/j.jmb.2013.01.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b14">
<cite>Ruberg F. L. &amp; Berk J. L.
Transthyretin (TTR) cardiac amyloidosis. Circulation
126, 1286–1300 (2012).</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.111.078915" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3501197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22949539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Transthyretin%20(TTR)%20cardiac%20amyloidosis&amp;author=F.%20L.%20Ruberg&amp;author=J.%20L.%20Berk&amp;volume=126&amp;publication_year=2012&amp;pages=1286-1300&amp;pmid=22949539&amp;doi=10.1161/CIRCULATIONAHA.111.078915&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b15">
<cite>Bergstrom J., Engstrom U., Yamashita T., Ando Y. &amp; Westermark P.
Surface exposed epitopes and structural heterogeneity of <em>in vivo</em> formed transthyretin amyloid fibrils. Biochem. Biophys. Res. Commun.
348, 532–539 (2006).</cite> [<a href="https://doi.org/10.1016/j.bbrc.2006.07.140" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16893521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;title=Surface%20exposed%20epitopes%20and%20structural%20heterogeneity%20of%20in%20vivo%20formed%20transthyretin%20amyloid%20fibrils&amp;author=J.%20Bergstrom&amp;author=U.%20Engstrom&amp;author=T.%20Yamashita&amp;author=Y.%20Ando&amp;author=P.%20Westermark&amp;volume=348&amp;publication_year=2006&amp;pages=532-539&amp;pmid=16893521&amp;doi=10.1016/j.bbrc.2006.07.140&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b16">
<cite>Chakrabartty A.
Progress in transthyretin fibrillogenesis research strengthens the amyloid hypothesis. PNAS.
98, 14757–14579 (2001).</cite> [<a href="https://doi.org/10.1073/pnas.261596398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC64929/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11752419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS.&amp;title=Progress%20in%20transthyretin%20fibrillogenesis%20research%20strengthens%20the%20amyloid%20hypothesis&amp;author=A.%20Chakrabartty&amp;volume=98&amp;publication_year=2001&amp;pages=14757-14579&amp;pmid=11752419&amp;doi=10.1073/pnas.261596398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b17">
<cite>Buxbaum J. N.
et al. Why are some amyloidosis systematic? Does hepatic “chaperoning at a distance” prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?
FASEB J.
26, 2283–2293 (2012).</cite> [<a href="https://doi.org/10.1096/fj.11-189571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3360152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22362898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FASEB%20J.&amp;title=Why%20are%20some%20amyloidosis%20systematic?%20Does%20hepatic%20%E2%80%9Cchaperoning%20at%20a%20distance%E2%80%9D%20prevent%20cardiac%20deposition%20in%20a%20transgenic%20model%20of%20human%20senile%20systemic%20(transthyretin)%20amyloidosis?&amp;author=J.%20N.%20Buxbaum&amp;volume=26&amp;publication_year=2012&amp;pages=2283-2293&amp;pmid=22362898&amp;doi=10.1096/fj.11-189571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b18">
<cite>Sipe J. D.
et al. Nomenclature: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid.
21, 221–224 (2014).</cite> [<a href="https://doi.org/10.3109/13506129.2014.964858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25263598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid.&amp;title=Nomenclature:%20Amyloid%20fibril%20proteins%20and%20clinical%20classification%20of%20the%20amyloidosis&amp;author=J.%20D.%20Sipe&amp;volume=21&amp;publication_year=2014&amp;pages=221-224&amp;pmid=25263598&amp;doi=10.3109/13506129.2014.964858&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b19">
<cite>Sekijima Y.
Recent progress in the understanding and treatment of transthyretin amyloidosis. J. Clin. Pharm. Ther.
39, 225–233 (2014).</cite> [<a href="https://doi.org/10.1111/jcpt.12145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24749898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Pharm.%20Ther.&amp;title=Recent%20progress%20in%20the%20understanding%20and%20treatment%20of%20transthyretin%20amyloidosis&amp;author=Y.%20Sekijima&amp;volume=39&amp;publication_year=2014&amp;pages=225-233&amp;pmid=24749898&amp;doi=10.1111/jcpt.12145&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b20">
<cite>Westermark P., Westermark G. T., Suhr O. B. &amp; Berg S.
Transthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis. Upsala. J. Med. Sci.
119, 223–228 (2014).</cite> [<a href="https://doi.org/10.3109/03009734.2014.895786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4116761/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24620715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Upsala.%20J.%20Med.%20Sci.&amp;title=Transthyretin-derived%20amyloidosis:%20Probably%20a%20common%20cause%20of%20lumbar%20spinal%20stenosis&amp;author=P.%20Westermark&amp;author=G.%20T.%20Westermark&amp;author=O.%20B.%20Suhr&amp;author=S.%20Berg&amp;volume=119&amp;publication_year=2014&amp;pages=223-228&amp;pmid=24620715&amp;doi=10.3109/03009734.2014.895786&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b21">
<cite>Sekijima Y.
et al. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpel tunnel syndrome in the elderly. Hum. Pathol.
42, 1785–1791 (2011).</cite> [<a href="https://doi.org/10.1016/j.humpath.2011.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21733562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Pathol.&amp;title=High%20prevalence%20of%20wild-type%20transthyretin%20deposition%20in%20patients%20with%20idiopathic%20carpal%20tunnel%20syndrome:%20a%20common%20cause%20of%20carpel%20tunnel%20syndrome%20in%20the%20elderly&amp;author=Y.%20Sekijima&amp;volume=42&amp;publication_year=2011&amp;pages=1785-1791&amp;pmid=21733562&amp;doi=10.1016/j.humpath.2011.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b22">
<cite>Dharmarajan K. &amp; Maurer M. S.
Transthyretin Cardiac Amyloidosis in older North Americans. J. Am. Geriatr. Soc.
60, 765–774 (2012).</cite> [<a href="https://doi.org/10.1111/j.1532-5415.2011.03868.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3325376/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22329529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Am.%20Geriatr.%20Soc.&amp;title=Transthyretin%20Cardiac%20Amyloidosis%20in%20older%20North%20Americans&amp;author=K.%20Dharmarajan&amp;author=M.%20S.%20Maurer&amp;volume=60&amp;publication_year=2012&amp;pages=765-774&amp;pmid=22329529&amp;doi=10.1111/j.1532-5415.2011.03868.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b23">
<cite>Rowzenio D. M.
et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum. Mutat.
35, e2403–2412 (2014).</cite> [<a href="https://doi.org/10.1002/humu.22619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25044787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Online%20registry%20for%20mutations%20in%20hereditary%20amyloidosis%20including%20nomenclature%20recommendations&amp;author=D.%20M.%20Rowzenio&amp;volume=35&amp;publication_year=2014&amp;pages=e2403-2412&amp;pmid=25044787&amp;doi=10.1002/humu.22619&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b24">
<cite>Ando Y.
et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet. J. Rare Dis.
8 (2013).</cite> [<a href="https://doi.org/10.1186/1750-1172-8-31" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584981/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23425518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet.%20J.%20Rare%20Dis.&amp;title=Guideline%20of%20transthyretin-related%20hereditary%20amyloidosis%20for%20clinicians&amp;author=Y.%20Ando&amp;volume=8&amp;publication_year=2013&amp;pmid=23425518&amp;doi=10.1186/1750-1172-8-31&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b25">
<cite>Bulawa C. E.
et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. PNAS.
109, 9629–9634 (2012).</cite> [<a href="https://doi.org/10.1073/pnas.1121005109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3386102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22645360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS.&amp;title=Tafamidis,%20a%20potent%20and%20selective%20transthyretin%20kinetic%20stabilizer%20that%20inhibits%20the%20amyloid%20cascade&amp;author=C.%20E.%20Bulawa&amp;volume=109&amp;publication_year=2012&amp;pages=9629-9634&amp;pmid=22645360&amp;doi=10.1073/pnas.1121005109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b26">
<cite>Pace C. N. &amp; McGrath T.
Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. J. Biol. Chem.
255, 3862–3865 (1980).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7372654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Substrate%20stabilization%20of%20lysozyme%20to%20thermal%20and%20guanidine%20hydrochloride%20denaturation&amp;author=C.%20N.%20Pace&amp;author=T.%20McGrath&amp;volume=255&amp;publication_year=1980&amp;pages=3862-3865&amp;pmid=7372654&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b27">
<cite>Kolstoe S. E.
et al. Trapping of palindromic ligands within native transthyretin prevents amyloid formation. PNAS.
107, 20483–8 (2010).</cite> [<a href="https://doi.org/10.1073/pnas.1008255107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2996680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21059958/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS.&amp;title=Trapping%20of%20palindromic%20ligands%20within%20native%20transthyretin%20prevents%20amyloid%20formation&amp;author=S.%20E.%20Kolstoe&amp;volume=107&amp;publication_year=2010&amp;pages=20483-8&amp;pmid=21059958&amp;doi=10.1073/pnas.1008255107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b28"><cite>FDA: Peripheral and Central Nervous System Drugs Advisory Committee report, 05-24-2012. Accessed on Oct. 23<sup>rd</sup>, 2015. Available from: <a href="http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM316336.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM316336.pdf</a>.</cite></li>
<li id="b29">
<cite>Scott Lesley. J.
Tafamidis: a review of its use in familial amyloid polyneuropathy. Drugs.
74, 1371–1378 (2014).</cite> [<a href="https://doi.org/10.1007/s40265-014-0260-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25022953/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs.&amp;title=Tafamidis:%20a%20review%20of%20its%20use%20in%20familial%20amyloid%20polyneuropathy&amp;author=Lesley.%20J.%20Scott&amp;volume=74&amp;publication_year=2014&amp;pages=1371-1378&amp;pmid=25022953&amp;doi=10.1007/s40265-014-0260-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b30">
<cite>Reichert J. M., Rosensweig C. J., Faden L. B. &amp; Dewitz M. C.
Monoclonal antibody successes in the clinic. Nat. Biotechnol.
23, 1073–1078 (2005).</cite> [<a href="https://doi.org/10.1038/nbt0905-1073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16151394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Biotechnol.&amp;title=Monoclonal%20antibody%20successes%20in%20the%20clinic&amp;author=J.%20M.%20Reichert&amp;author=C.%20J.%20Rosensweig&amp;author=L.%20B.%20Faden&amp;author=M.%20C.%20Dewitz&amp;volume=23&amp;publication_year=2005&amp;pages=1073-1078&amp;pmid=16151394&amp;doi=10.1038/nbt0905-1073&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b31">
<cite>Kola I. &amp; Landis J.
Can the pharmaceutical industry reduce attrition rates?
Nat. Rev. Drug Discov.
3, 711–715 (2004).</cite> [<a href="https://doi.org/10.1038/nrd1470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15286737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Drug%20Discov.&amp;title=Can%20the%20pharmaceutical%20industry%20reduce%20attrition%20rates?&amp;author=I.%20Kola&amp;author=J.%20Landis&amp;volume=3&amp;publication_year=2004&amp;pages=711-715&amp;pmid=15286737&amp;doi=10.1038/nrd1470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b32">
<cite>Rakhit R.
et al. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat. Med.
13, 754–759 (2007).</cite> [<a href="https://doi.org/10.1038/nm1559" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17486090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=An%20immunological%20epitope%20selective%20for%20pathological%20monomer-misfolded%20SOD1%20in%20ALS&amp;author=R.%20Rakhit&amp;volume=13&amp;publication_year=2007&amp;pages=754-759&amp;pmid=17486090&amp;doi=10.1038/nm1559&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b33">
<cite>Paramithiotis E.
et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med.
9, 893–899 (2003).</cite> [<a href="https://doi.org/10.1038/nm883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12778138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=A%20prion%20protein%20epitope%20selective%20for%20the%20pathologically%20misfolded%20conformation&amp;author=E.%20Paramithiotis&amp;volume=9&amp;publication_year=2003&amp;pages=893-899&amp;pmid=12778138&amp;doi=10.1038/nm883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b34">
<cite>Kayed R.
et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science
300, 486–489 (2003).</cite> [<a href="https://doi.org/10.1126/science.1079469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12702875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Common%20structure%20of%20soluble%20amyloid%20oligomers%20implies%20common%20mechanism%20of%20pathogenesis&amp;author=R.%20Kayed&amp;volume=300&amp;publication_year=2003&amp;pages=486-489&amp;pmid=12702875&amp;doi=10.1126/science.1079469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b35">
<cite>Goldsteins G.
et al. Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants. PNAS
96, 3108–3113 (1999).</cite> [<a href="https://doi.org/10.1073/pnas.96.6.3108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC15903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10077645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS&amp;title=Exposure%20of%20cryptic%20epitopes%20on%20transthyretin%20only%20in%20amyloid%20and%20in%20amyloidogenic%20mutants&amp;author=G.%20Goldsteins&amp;volume=96&amp;publication_year=1999&amp;pages=3108-3113&amp;pmid=10077645&amp;doi=10.1073/pnas.96.6.3108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b36">
<cite>Palha J. A., Moreira P., Olofsson A., Lundgren E. &amp; Saraiva M. J.
Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy. J. Mol. Med. (Berl).
78, 703–707 (2001).</cite> [<a href="https://doi.org/10.1007/s001090000163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11434723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Med.%20(Berl).&amp;title=Antibody%20recognition%20of%20amyloidogenic%20transthyretin%20variants%20in%20serum%20of%20patients%20with%20familial%20amyloidotic%20polyneuropathy&amp;author=J.%20A.%20Palha&amp;author=P.%20Moreira&amp;author=A.%20Olofsson&amp;author=E.%20Lundgren&amp;author=M.%20J.%20Saraiva&amp;volume=78&amp;publication_year=2001&amp;pages=703-707&amp;pmid=11434723&amp;doi=10.1007/s001090000163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b37">
<cite>Lai Z., McCulloch J., Lashuel H. A. &amp; Kelly J. W.
Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry
36, 10230–10239 (1997).</cite> [<a href="https://doi.org/10.1021/bi963195p" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9254621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Guanidine%20hydrochloride-induced%20denaturation%20and%20refolding%20of%20transthyretin%20exhibits%20a%20marked%20hysteresis:%20equilibria%20with%20high%20kinetic%20barriers&amp;author=Z.%20Lai&amp;author=J.%20McCulloch&amp;author=H.%20A.%20Lashuel&amp;author=J.%20W.%20Kelly&amp;volume=36&amp;publication_year=1997&amp;pages=10230-10239&amp;pmid=9254621&amp;doi=10.1021/bi963195p&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b38">
<cite>Wemmer D. E., Liu K., Cho H. S., Lashuel H. A. &amp; Kelly J. W.
A glimpse of a possible amyloidogenic intermediate of transthyretin. Nat. Struct. Biol.
7, 754–757 (2000).</cite> [<a href="https://doi.org/10.1038/78980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10966644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Biol.&amp;title=A%20glimpse%20of%20a%20possible%20amyloidogenic%20intermediate%20of%20transthyretin&amp;author=D.%20E.%20Wemmer&amp;author=K.%20Liu&amp;author=H.%20S.%20Cho&amp;author=H.%20A.%20Lashuel&amp;author=J.%20W.%20Kelly&amp;volume=7&amp;publication_year=2000&amp;pages=754-757&amp;pmid=10966644&amp;doi=10.1038/78980&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b39">
<cite>Lai Z., Colon W. &amp; Kelly J. W. (1996). The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry
35, 6470–6482.</cite> [<a href="https://doi.org/10.1021/bi952501g" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8639594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=The%20acid-mediated%20denaturation%20pathway%20of%20transthyretin%20yields%20a%20conformational%20intermediate%20that%20can%20self-assemble%20into%20amyloid&amp;author=Z.%20Lai&amp;author=W.%20Colon&amp;author=J.%20W.%20Kelly&amp;volume=35&amp;pages=6470-6482&amp;pmid=8639594&amp;doi=10.1021/bi952501g&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b40">
<cite>Arslan P. E., Mulligan V. K., Ho S. &amp; Chakrabartty A.
Conversion of Abeta42 into a folded soluble native-like protein using a semi-random library of amphipathic helices. J. Mol. Biol.
396, 1284–1294 (2010).</cite> [<a href="https://doi.org/10.1016/j.jmb.2009.12.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20026077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Conversion%20of%20Abeta42%20into%20a%20folded%20soluble%20native-like%20protein%20using%20a%20semi-random%20library%20of%20amphipathic%20helices&amp;author=P.%20E.%20Arslan&amp;author=V.%20K.%20Mulligan&amp;author=S.%20Ho&amp;author=A.%20Chakrabartty&amp;volume=396&amp;publication_year=2010&amp;pages=1284-1294&amp;pmid=20026077&amp;doi=10.1016/j.jmb.2009.12.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b41">
<cite>Jiang X., Buxbaum J. N. &amp; Kelly J. W.
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. PNAS.
98, 14943–14948 (2001).</cite> [<a href="https://doi.org/10.1073/pnas.261419998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC64963/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11752443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS.&amp;title=The%20V122I%20cardiomyopathy%20variant%20of%20transthyretin%20increases%20the%20velocity%20of%20rate-limiting%20tetramer%20dissociation,%20resulting%20in%20accelerated%20amyloidosis&amp;author=X.%20Jiang&amp;author=J.%20N.%20Buxbaum&amp;author=J.%20W.%20Kelly&amp;volume=98&amp;publication_year=2001&amp;pages=14943-14948&amp;pmid=11752443&amp;doi=10.1073/pnas.261419998&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b42">
<cite>Redondo C., Damas A. M., Olofsson A., Lundgren E. &amp; Saraiva M. J.
Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils. J. Mol. Biol.
304, 461–470 (2000).</cite> [<a href="https://doi.org/10.1006/jmbi.2000.4220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11090287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Search%20for%20intermediate%20structures%20in%20transthyretin%20fibrillogenesis:%20soluble%20tetrameric%20Tyr78Phe%20TTR%20expresses%20a%20specific%20epitope%20present%20only%20in%20amyloid%20fibrils&amp;author=C.%20Redondo&amp;author=A.%20M.%20Damas&amp;author=A.%20Olofsson&amp;author=E.%20Lundgren&amp;author=M.%20J.%20Saraiva&amp;volume=304&amp;publication_year=2000&amp;pages=461-470&amp;pmid=11090287&amp;doi=10.1006/jmbi.2000.4220&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b43">
<cite>Saelices L.
et al. Uncovering the Mechanism of Aggregation of Human Transthyretin. J. Biol. Chem.
290, 28932–27943 (2015).</cite> [<a href="https://doi.org/10.1074/jbc.M115.659912" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4661406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26459562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Uncovering%20the%20Mechanism%20of%20Aggregation%20of%20Human%20Transthyretin&amp;author=L.%20Saelices&amp;volume=290&amp;publication_year=2015&amp;pages=28932-27943&amp;pmid=26459562&amp;doi=10.1074/jbc.M115.659912&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b44">
<cite>Goldschmidt L., Teng P. K., Riek R. &amp; Eisenberg D.
Identifying the amyloid proteins capable of forming amyloid-like fibrils. PNAS.
107, 3487–3492 (2010).</cite> [<a href="https://doi.org/10.1073/pnas.0915166107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2840437/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20133726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PNAS.&amp;title=Identifying%20the%20amyloid%20proteins%20capable%20of%20forming%20amyloid-like%20fibrils&amp;author=L.%20Goldschmidt&amp;author=P.%20K.%20Teng&amp;author=R.%20Riek&amp;author=D.%20Eisenberg&amp;volume=107&amp;publication_year=2010&amp;pages=3487-3492&amp;pmid=20133726&amp;doi=10.1073/pnas.0915166107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b45">
<cite>Higaki J. N.
et al. Amyloid. doi: 10.3109/13506129.2016.1148025. Article in press (2016).</cite> [<a href="https://doi.org/10.3109/13506129.2016.1148025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>]</li>
<li id="b46">
<cite>Sechi S. &amp; Chait B. T.
Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Anal Chem.
70, 5150–5158 (1998).</cite> [<a href="https://doi.org/10.1021/ac9806005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9868912/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anal%20Chem.&amp;title=Modification%20of%20cysteine%20residues%20by%20alkylation.%20A%20tool%20in%20peptide%20mapping%20and%20protein%20identification&amp;author=S.%20Sechi&amp;author=B.%20T.%20Chait&amp;volume=70&amp;publication_year=1998&amp;pages=5150-5158&amp;pmid=9868912&amp;doi=10.1021/ac9806005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="b47">
<cite>Pettersen E. F.
et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem.
25, 1605–1612 (2004).</cite> [<a href="https://doi.org/10.1002/jcc.20084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15264254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Chem.&amp;title=UCSF%20Chimera-a%20visualization%20system%20for%20exploratory%20research%20and%20analysis&amp;author=E.%20F.%20Pettersen&amp;volume=25&amp;publication_year=2004&amp;pages=1605-1612&amp;pmid=15264254&amp;doi=10.1002/jcc.20084&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplementary Information</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/4848561/bin/srep25080-s1.pdf" data-ga-action="click_feat_suppl" class="usa-link">srep25080-s1.pdf</a><sup> (917.7KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/srep25080"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/srep25080.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/4848561/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/4848561/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC4848561%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC4848561/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC4848561/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC4848561/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/27122057/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC4848561/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/27122057/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC4848561/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/4848561/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Zjw1u22tgRiaeIOfPsZzjwVWcdkl23pd02jIXNqFddxGyb7A3G4f7anwX1AVFD6R">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
